We are monitoring the impact of COVID-19 on North America Plasma Protein Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 206
Share on
Share on

North America Plasma Protein Therapeutics Market Research Report – Segmented By Product Type, Application & Country (The United States, Canada and Rest of North America) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2021 to 2026)

Pulished: April, 2021
ID: 206
Pages: 135

North America Plasma Protein Therapeutics Market Size (2021 to 2026)

The North American Plasma Protein Therapeutics Market is currently valued to be USD 9294.69 Million in 2021 and held the most dominant share in the global market and is estimated to reach USD 13956.71 Million by the end of 2026, registering a CAGR of 8.47% between 2021 to 2026.

Recent years have witnessed the increased usage of plasma proteins in medical applications. The advancements in technology have made the process for fractionating the protein from plasma more efficient and cost-saving and is a huge boost to the market. Reports suggest that half of the global blood donors are from high-income countries, constituting only 18% of the global population. Rising awareness among individuals regarding the significance of blood donations and government initiatives helped the market propel the market significantly.

Plasma, a protein-rich fluid, plays a critical role in clotting and providing immunity to diseases. Isolating these proteins from plasma can help various medical therapies, including immune deficiencies, autoimmune, bleeding, and neurological disorders. By replacing the missing or deficient proteins in plasma, plasma protein therapies can treat life-threatening genetic and chronic diseases.

The rising number of new plasma-derived therapies has increased the demand for the market in recent years. The rising prevalence of life-threatening diseases that involve the neurological or immune system and other infectious diseases like Tetanus, Rabies, varicella, and Hepatitis A&B are some of the factors enabling the growth of the market.

However, a few restraints may prove to be a bottleneck for the growth of the market, including stringent regulatory policies, reimbursement issues, and manufacturing complexity.  

This research report on the North America Plasma Protein Therapeutics Market has been segmented and sub-segmented into the following categories:

By Type: 

  • Immunoglobulins
  • Albumin
  • Coagulation Factor
  • Alpha-1 Proteinase Inhibitor
  • Others

By Application: 

  • Hemophilia
  • Primary Immunodeficiency Disorder
  • Idiopathic Thrombocytopenic Purpura
  • Secondary Immunodeficiency
  • Others

By Country: 

  • The United States
  • Canada
  • Rest of North America

Grifols, CSL Behring, Baxter, Krdrion, China Biologics, Octapharma, Chendu Inst, and Shire Plc play a leading role in the North American Plasma Protein Therapeutics Market.

1. Introduction                                                                                                 

                1.1 Market Definition                                                                                    

                1.2 Study Deliverables                                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                                          

                1.4 General Study Assumptions                                                                                

2. Research Methodology                                                                                                           

                2.1 Introduction                                                                                               

                2.2 Research Phases                                                                                      

                                2.2.1 Secondary Research                                                                           

                                2.2.2 Primary Research                                                                 

                                2.2.3 Econometric Modelling                                                                      

                                2.2.4 Expert Validation                                                                  

                2.3 Analysis Design                                                                                         

                2.4 Study Timeline                                                                                          

3. Overview                                                                                                       

                3.1 Executive Summary                                                                                

                3.2 Key Inferences                                                                                         

                3.3 New Developments                                                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                                    

                4.1 Market Drivers                                                                                          

                4.2 Market Restraints                                                                                    

                4.3 Key Challenges                                                                                         

                4.4 Current Opportunities in the Market                                                                                              

5. Market Segmentation                                                                                                              

                5.1 By Type                                                                                        

                                5.1.1 Immunoglobulins                                                                 

                                5.1.2 Albumin                                                                   

                                5.1.3 Coagulation Factors                                                                             

                                5.1.4 Alpha-1 proteinase inhibitor                                                                            

                                5.1.5 Others                                                                      

                5.2 By Application                                                                                           

                                5.2.1 Hemophilia                                                                             

                                5.2.2 Primary Immunodeficiency Disorder                                                                           

                                5.2.3 Idiopathic Thrombocytopenic Purpura                                                                        

                                5.2.4 Secondary Immunodeficiency                                                                        

                                5.2.5 Others                                                                      

6. Geographical Analysis                                                                                                              

                6.1 Introduction                                                                                               

                6.2 United States                                                                                            

                6.3 Canada                                                                                         

7. Strategic Analysis                                                                                                       

                7.1 PESTLE analysis                                                                                         

                                7.1.1 Political                                                                     

                                7.1.2 Economic                                                                 

                                7.1.3 Social                                                                         

                                7.1.4 Technological                                                                         

                                7.1.5 Legal                                                                          

                                7.1.6 Environmental                                                                       

                7.2 Porter’s Five analysis                                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                                        

                                7.2.2 Bargaining Power of Consumers                                                                    

                                7.2.3 Threat of New Entrants                                                                     

                                7.2.4 Threat of Substitute Products and Services                                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                                     

8. Market Leaders' Analysis                                                                                                        

                8.1 CSL Behring                                                                

                                8.1.1 Overview                                                                 

                                8.1.2 Product Analysis                                                                   

                                8.1.3 Strategic Evaluation and Operations                                                                            

                                8.1.4 Financial analysis                                                                  

                                8.1.5 Legal issues                                                                             

                                8.1.6 Recent Developments                                                                       

                                8.1.7 SWOT analysis                                                                       

                                8.1.8 Analyst View                                                                          

                8.2 Baxter                                                                           

                8.3 Biotest                                                                          

                8.4 China Biologics                                                                          

                8.5 Grifols                                                                           

                8.6 Kedrion                                                                        

                8.7 Octapharma                                                                               

                8.8 Shire Plc.                                                                      

                8.9 Chengdu Inst.                                                                            

9. Competitive Landscape                                                                                                           

                9.1 Market share analysis                                                                                            

                9.2 Merger and Acquisition Analysis                                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                                         

                9.4 New Product Launches                                                                                         

10. Expert Opinions                                                                                                        

                10.1 Market Outlook                                                                                     

                10.2 Investment Opportunities                                                                                 


                a) List of Tables                                                                                

                b) List of Figures                                                                                              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Plasma Protein Therapeutics Market, By Type, From 2021 to 2026 (USD Million)
  2. North America Plasma Protein Therapeutics Market, By Application From 2021 to 2026 (USD Million)
  3. North America Immunoglobulins Market, By Region, From 2021 to 2026 (USD Million)
  4. North America Albumin Market, By Region, From 2021 to 2026 (USD Million)
  5. North America Coagulation Factors Market, By Region, From 2021 to 2026 (USD Million)
  6. North America Alpha-1 proteinase inhibitor Market, By Region, From 2021 to 2026 (USD Million)
  7. North America Others Market, By Region, From 2021 to 2026 (USD Million)
  8. North America Hemophilia Market, By Region, From 2021 to 2026 (USD Million)
  9. North America Primary Immunodeficiency Disorder Market, By Region, From 2021 to 2026 (USD Million)
  10. North America Idiopathic Thrombocytopenic Purpura Market, By Region, From 2021 to 2026 (USD Million)
  11. North America Secondary Immunodeficiency Market, By Region, From 2021 to 2026 (USD Million)
  12. North America Others Market, By Region, From 2021 to 2026 (USD Million)
  13. United States Plasma Protein Therapeutics Market, By Type, From 2021 to 2026 (USD Million)
  14. Canada Plasma Protein Therapeutics Market, By Type, From 2021 to 2026 (USD Million)
  15. United States Plasma Protein Therapeutics Market, By Application, From 2021 to 2026 (USD Million)
  16. Canada Plasma Protein Therapeutics Market, By Application, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample